Report finds EMR market competition heating up

Stiffer competition between key vendors is causing a growing number of providers to be undecided about which EMR to purchase when looking to make a buying decision, according to a new report from KLAS. 

Even though providers have fewer choices due to market contraction, they are less likely to have made up their minds about which system to buy when evaluating future purchases, according to the acute care EMR purchasing plans report.

Much market activity is driven by legacy customers seeking to upgrade or replace their system.

"The competition between Epic and Cerner is closer than it has been in years past as customers determine their future purchasing plans. This has left twice as many facilities "up for grabs" as there were last year," said report author Coray Tate. "The lion's share of the remaining customer mindshare is split between MEDITECH and McKesson, pretty consistently along partisan lines."

The report is available for purchase.

 

 

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.